findmyKOL
Clinical trialNCT00381641CompletedPhase 2Interventional

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

SponsorNational Cancer Institute (NCI)Enrollment63Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaRefractory Thyroid Gland CarcinomaStage III Thyroid Gland Follicular Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7Stage IV Thyroid Gland Follicular Carcinoma AJCC v7+13 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Decatur Memorial Hospital

    Decatur, Illinois, United States

  • Northshore University Healthsystem-Evanston Hospital

    Evanston, Illinois, United States

  • Ingalls Memorial Hospital

    Harvey, Illinois, United States

  • Duly Health and Care Joliet

    Joliet, Illinois, United States

  • Loyola University Medical Center

    Maywood, Illinois, United States

  • Illinois Cancercare-Peoria

    Peoria, Illinois, United States

  • Central Illinois Hematology Oncology Center

    Springfield, Illinois, United States

  • Southern Illinois University School of Medicine

    Springfield, Illinois, United States

  • Fort Wayne Medical Oncology and Hematology Inc-Parkview

    Fort Wayne, Indiana, United States

  • Northern Indiana Cancer Research Consortium

    South Bend, Indiana, United States

  • University of Maryland/greenebaum Cancer Center

    Baltimore, Maryland, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

  • Oncology Care Associates Pllc

    Saint Joseph, Michigan, United States

  • Mercy Hospital Saint Louis

    St Louis, Missouri, United States

  • M D Anderson Cancer Center

    Houston, Texas, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Aug 2006
Primary completion
31 Dec 2016
Completion
10 Dec 2024
Last update posted
28 Mar 2025
Registered enrollment
63
Registry id
NCT00381641

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.